JP2015510517A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015510517A5 JP2015510517A5 JP2014557799A JP2014557799A JP2015510517A5 JP 2015510517 A5 JP2015510517 A5 JP 2015510517A5 JP 2014557799 A JP2014557799 A JP 2014557799A JP 2014557799 A JP2014557799 A JP 2014557799A JP 2015510517 A5 JP2015510517 A5 JP 2015510517A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- unsubstituted
- substituted
- als
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261599096P | 2012-02-15 | 2012-02-15 | |
| US61/599,096 | 2012-02-15 | ||
| PCT/US2013/026284 WO2013123290A1 (en) | 2012-02-15 | 2013-02-15 | Methods of treating amyotrophic lateral sclerosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015510517A JP2015510517A (ja) | 2015-04-09 |
| JP2015510517A5 true JP2015510517A5 (enExample) | 2016-03-24 |
| JP6173352B2 JP6173352B2 (ja) | 2017-08-02 |
Family
ID=48984729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014557799A Expired - Fee Related JP6173352B2 (ja) | 2012-02-15 | 2013-02-15 | 筋萎縮性側索硬化症の治療方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9340483B2 (enExample) |
| EP (1) | EP2814479B1 (enExample) |
| JP (1) | JP6173352B2 (enExample) |
| CA (1) | CA2864797C (enExample) |
| WO (1) | WO2013123290A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3050572A1 (en) * | 2017-01-18 | 2018-07-26 | Universitat Autonoma De Barcelona | Specialized pro-resolving lipid mediators for use in the treatment of neurodegenerative diseases and/or autoimmune diseases |
| WO2019016580A1 (en) | 2017-07-20 | 2019-01-24 | Universitat Autonoma De Barcelona | MARESINS FOR USE IN THE TREATMENT OF CNS INJURIES |
| US10322114B2 (en) | 2017-07-31 | 2019-06-18 | Above And Beyond Nb, Llc | Formulation of a riluzole solution with beta-cyclodextrins |
| US20250381161A1 (en) * | 2022-06-21 | 2025-12-18 | Anida Pharma Inc. | Compositions and methods for treating hearing and ocular disorders |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1202068C (zh) | 2000-02-16 | 2005-05-18 | 布里格姆及妇女医院股份有限公司 | 阿司匹林触发的脂质介体 |
| AU2002343609B2 (en) * | 2001-11-16 | 2008-12-11 | Als Therapy Development Foundation, Inc. | Treatment of neurodegenerative disorders through the modulation of the polyamine pathway |
| US7759395B2 (en) | 2002-08-12 | 2010-07-20 | The Brigham And Women's Hospital, Inc. | Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma |
| WO2004093802A2 (en) * | 2003-04-17 | 2004-11-04 | The Board Of Trustees Of The Leland Stanford Junior University | Prevention of deficits in neurogenesis with anti-inflammatory agents |
| EP1660069A4 (en) * | 2003-08-05 | 2009-03-18 | Univ Louisiana State | NEUROPROTECTION AGAINST CELL APOPTOSIS, NEURAL STROKES, ALZHEIMER DISEASE AND RETINAL DEGENERATION |
| DK1691814T3 (da) * | 2003-12-01 | 2012-10-29 | Cambridge Entpr Ltd | Antiinflammatoriske midler |
| WO2007041440A2 (en) * | 2005-10-03 | 2007-04-12 | The Brigham And Women's Hospital, Inc. | Anti-inflammatory actions of neuroprotectin d1/protectin d1 and its natural stereoisomers |
| US20110190389A1 (en) | 2007-02-20 | 2011-08-04 | Linda Arterburn | Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same |
| WO2009018333A2 (en) | 2007-07-30 | 2009-02-05 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Dha and pedf, a therapeutic composition for nerve and retinal pigment epithelial cells |
| GB2452696B (en) * | 2007-08-02 | 2009-09-23 | Cambridge Entpr Ltd | 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions |
| US20090137527A1 (en) | 2007-09-14 | 2009-05-28 | Resolvyx Pharmaceuticals, Inc. | Compositions and methods for modulating immune function |
| WO2009056983A1 (en) | 2007-10-31 | 2009-05-07 | Pronova Biopharma Norge As | New dha derivatives and their use as medicaments |
| US7782152B2 (en) | 2008-08-14 | 2010-08-24 | Broadcom Corporation | Monotonic frequency tuning technique for DCXO in cellular applications |
| US20120122816A1 (en) | 2009-02-05 | 2012-05-17 | Resolvyx Pharmaceuticals, Inc. | Compositions and methods for organ preservation |
| US9468620B2 (en) * | 2013-02-28 | 2016-10-18 | Andida Pharma, Inc. | Methods of treating ototoxicity |
-
2013
- 2013-02-15 JP JP2014557799A patent/JP6173352B2/ja not_active Expired - Fee Related
- 2013-02-15 US US14/379,177 patent/US9340483B2/en active Active
- 2013-02-15 CA CA2864797A patent/CA2864797C/en active Active
- 2013-02-15 WO PCT/US2013/026284 patent/WO2013123290A1/en not_active Ceased
- 2013-02-15 EP EP13748858.1A patent/EP2814479B1/en active Active